2009 HCPCS S2107
Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g. tumor-infiltrating lymphocyte therapy) per course of treatment

  • This is the 2009 version of HCPCS S2107 - please refer to the 2016 HCPCS code set for the latest version.
  • Added on Monday, April 01, 2002
  • Status changed on Monday, April 01, 2002 to: No maintenance for this code
  • BETOS Classification: Undefined Codes
  • Medicare coverage status: Not payable by Medicare (no grace period)

  S2103    S2112